|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1 Pt 1
|
|
pubmed:dateCreated |
1995-8-1
|
|
pubmed:abstractText |
The purpose of this trial was to determine whether 20 days of antimicrobial treatment is more efficacious than 10 days of treatment for acute otitis media (AOM) in clearing middle ear effusion and preventing recurrences of AOM, and whether changing to a beta-lactamase-stable antimicrobial agent after the initial 10-day treatment with amoxicillin for AOM is advantageous.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0031-4005
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
96
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
5-13
|
|
pubmed:dateRevised |
2010-3-24
|
|
pubmed:meshHeading |
pubmed-meshheading:7596722-Acute Disease,
pubmed-meshheading:7596722-Amoxicillin,
pubmed-meshheading:7596722-Child,
pubmed-meshheading:7596722-Child, Preschool,
pubmed-meshheading:7596722-Clavulanic Acid,
pubmed-meshheading:7596722-Clavulanic Acids,
pubmed-meshheading:7596722-Double-Blind Method,
pubmed-meshheading:7596722-Drug Administration Schedule,
pubmed-meshheading:7596722-Drug Therapy, Combination,
pubmed-meshheading:7596722-Female,
pubmed-meshheading:7596722-Humans,
pubmed-meshheading:7596722-Infant,
pubmed-meshheading:7596722-Male,
pubmed-meshheading:7596722-Otitis Media,
pubmed-meshheading:7596722-Otitis Media with Effusion,
pubmed-meshheading:7596722-Patient Compliance,
pubmed-meshheading:7596722-Prognosis,
pubmed-meshheading:7596722-Recurrence,
pubmed-meshheading:7596722-Treatment Outcome,
pubmed-meshheading:7596722-beta-Lactamases
|
|
pubmed:year |
1995
|
|
pubmed:articleTitle |
Efficacy of 20- versus 10-day antimicrobial treatment for acute otitis media.
|
|
pubmed:affiliation |
Department of Pediatric Otolaryngology, Children's Hospital of Pittsburgh, PA 15213-2583, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.,
Randomized Controlled Trial
|
